Establishment Labs (ESTA) Jefferies Global Healthcare Conference summary

Company overview and innovation

• Founded to address high complication rates in plastic surgery by introducing advanced technology that reduces device-related complications, especially capsular contracture and rupture.

• Achieved industry-leading reduction in reoperations and continues to innovate for better patient outcomes.

Global commercial strategy and market expansion

• Employs a blueprint focused on surgeon education and direct-to-consumer outreach where compliant, leading to gradual market leadership.

• Innovations have reduced incision sizes and enabled more patient-friendly procedures, driving demand.

• Market leadership is achieved through years of education and technology adoption, not overnight success.

Mia minimally invasive procedure rollout

• Developed Mia, a minimally invasive breast augmentation using injectable super silicone implants, performed in under 15 minutes without general anesthesia.

• Mia is expanding the market by attracting new consumers and is being rolled out city-by-city in Europe, Japan, and the Middle East.

• Some partner centers are trending toward $1 million annual run rates, with an aspirational goal of 100 centers by year-end.